|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
|
ISS |
OMIM:104000 | OMIM:610753 |
MouseDO |
|
|
NCBI chr20:3,210,383...3,223,187
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
susceptibility |
ISO |
DNA:SNP:3'UTR:rs3087243(human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20596022 PMID:23567921 |
RGD:7411701 |
NCBI chr 9:69,812,859...69,819,959
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22358057 |
|
NCBI chr14:15,989,066...15,991,263
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22358057 |
|
NCBI chr14:16,007,166...16,012,077
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22358057 |
|
NCBI chr X:70,884,293...70,886,944
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
mRNA:increased expression:mononuclear cell: |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr 8:27,716,797...27,763,405
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
|
ISO |
mRNA:increased expression:mononuclear cell: |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr20:3,924,263...3,941,238
|
|
G |
Hdac1 |
histone deacetylase 1 |
|
ISO |
mRNA:increased expression:mononuclear cell: |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr 5:147,138,328...147,165,387
|
|
G |
Hdac2 |
histone deacetylase 2 |
|
ISO |
mRNA:decreased expression:mononuclear cell: |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr20:42,101,815...42,126,486
|
|
G |
Hdac7 |
histone deacetylase 7 |
|
ISO |
mRNA:decreased expression:mononuclear cell: |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr 7:130,803,013...130,841,181
|
|
G |
Ikzf4 |
IKAROS family zinc finger 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20596022 |
|
NCBI chr 7:1,643,379...1,687,524
|
|
G |
Il18 |
interleukin 18 |
susceptibility |
ISO |
DNA:SNPs:promoter, exon:-137G>C (rs187238), rs549908 (human) |
RGD |
PMID:24446726 |
RGD:8655875 |
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
severity |
ISO |
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human) |
RGD |
PMID:8077705 |
RGD:6909137 |
NCBI chr 3:27,509,836...27,525,738
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:3261574 PMID:16297194 |
RGD:8663449, RGD:8663450 |
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20596022 |
|
NCBI chr17:71,759,802...71,808,475
|
|
G |
Kdm1a |
lysine demethylase 1A |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr 5:154,066,436...154,121,913
|
|
G |
Kdm4a |
lysine demethylase 4A |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr 5:136,958,178...137,004,942
|
|
G |
Kdm4b |
lysine demethylase 4B |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr 9:1,245,885...1,324,384
|
|
G |
Kdm4c |
lysine demethylase 4C |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr 5:93,146,404...93,353,040
|
|
G |
Kdm5a |
lysine demethylase 5A |
|
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:21936853 |
RGD:9587460 |
NCBI chr 4:155,238,124...155,316,121
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
onset |
ISO |
DNA:SNP:intron 6:g.9959C>T (human) |
RGD |
PMID:10942113 |
RGD:126777672 |
NCBI chr11:50,269,056...50,294,699
|
|
G |
Notch4 |
notch receptor 4 |
|
ISO |
|
RGD |
PMID:12589427 |
RGD:6480681 |
NCBI chr20:4,164,969...4,189,072
|
|
G |
Prdx5 |
peroxiredoxin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20596022 |
|
NCBI chr 1:213,529,042...213,532,787
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 |
severity |
ISO |
DNA:snp:cds:c.1858C>T (human) |
RGD |
PMID:16829308 |
RGD:6484734 |
NCBI chr 2:194,055,165...194,103,209
|
|
G |
Raet1l |
retinoic acid early transcript 1L |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20596022 |
|
NCBI chr 1:3,799,823...3,804,799
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
DNA:polymorphism: : HLA-DQA1*0104, HLA-DQA1*0606; |
RGD |
PMID:16231148 |
RGD:8547568 |
NCBI chr20:4,577,057...4,581,650
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
DNA:polymorphism: : HLA-DQB1*0604; |
RGD |
PMID:16231148 |
RGD:8547568 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
Stx17 |
syntaxin 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20596022 |
|
NCBI chr 5:67,241,673...67,302,228
|
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
|
ISO |
protein:increased expression:blister, serum (human) |
RGD |
PMID:21881593 |
RGD:11087555 |
NCBI chr12:26,745,972...26,750,924
|
|
G |
Cfb |
complement factor B |
|
ISO |
|
RGD |
PMID:17024247 |
RGD:7421522 |
NCBI chr20:3,975,271...3,981,138
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:21488867 |
RGD:5147756 |
NCBI chr 3:98,051,958...98,065,246
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:1377725 |
RGD:8547591 |
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:1973607 |
RGD:8663461 |
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
|
RGD |
PMID:9687525 |
RGD:8547843 |
NCBI chr 3:174,103,474...174,111,434
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
mRNA:increased expression: : |
RGD |
PMID:7738351 |
RGD:7421578 |
NCBI chr 9:22,452,854...22,468,194
|
|
|
G |
Clu |
clusterin |
|
ISO |
mRNA:decreased expression:conjunctiva |
RGD |
PMID:12036968 |
RGD:8699507 |
NCBI chr15:44,336,619...44,375,861
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:11448121 |
RGD:8549794 |
NCBI chr 3:27,509,836...27,525,738
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21966456 |
|
NCBI chr 2:249,264,985...249,409,966
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
DNA:polymorphisms, haplotypes:cds:HLA-DQB1*0301, HLA-DQB1*0201 (human) DNA:polymorphism:cds:HLA-DQB1*0301 (human) |
RGD |
PMID:9683867 PMID:9008223 |
RGD:7365096, RGD:7483589 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
DNA:polymorphism: :DRB1*1101, DRB1*0701(human) DNA:polymorphism: :HLA-DRB1*04(human) |
RGD |
PMID:9683867 PMID:8052655 |
RGD:7365096, RGD:7365103 |
NCBI chr20:4,550,594...4,560,182
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:Conjunctiva: |
RGD |
PMID:7750940 |
RGD:7394786 |
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Eln |
elastin |
|
ISO |
|
RGD |
PMID:8256113 |
RGD:9585750 |
NCBI chr12:27,604,983...27,648,413
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
DNA:polymorphism |
RGD |
PMID:7914110 |
RGD:8548777 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
DNA:polymorphism:promoter |
RGD |
PMID:7914110 |
RGD:8548777 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
mRNA:increased expression: : |
RGD |
PMID:7738351 |
RGD:7421578 |
NCBI chr 9:22,452,854...22,468,194
|
|
|
G |
Atp2c1 |
ATPase secretory pathway Ca2+ transporting 1 |
|
ISO |
ClinVar Annotator: match by term: ATP2C1-related condition | ClinVar Annotator: match by term: Familial benign pemphigus CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:3978039 PMID:10615129 PMID:10767338 PMID:11450592 PMID:11874499 PMID:15545997 PMID:16621454 PMID:20338123 PMID:21883398 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr 8:114,913,551...115,034,706
|
|
|
G |
Dstyk |
dual serine/threonine and tyrosine protein kinase |
|
ISO |
ClinVar Annotator: match by term: DSTYK-related condition | ClinVar Annotator: match by term: Hereditary spastic paraplegia 23 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:17273976 PMID:23862974 PMID:25741868 PMID:27657687 PMID:28492532 PMID:28566479 PMID:33624863 More...
|
|
NCBI chr13:46,409,412...46,457,426
|
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16538176 |
|
NCBI chr20:4,872,720...4,876,425
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16538176 |
|
NCBI chr20:3,261,656...3,265,548
|
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:74171 |
|
NCBI chr 9:2,174,412...2,201,339
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:16314468 |
RGD:5509814 |
NCBI chr 2:5,707,633...5,817,213
|
|
G |
Cat |
catalase |
|
ISO |
protein:increased activities:skin: |
RGD |
PMID:22738420 |
RGD:9479165 |
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
|
RGD |
PMID:21255096 |
RGD:5490304 |
NCBI chr 4:18,209,088...18,302,142
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:21255096 |
RGD:5490304 |
NCBI chr 3:174,209,113...174,224,592
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
mRNA, protein:increased expression:skin, serum |
RGD |
PMID:17531537 |
RGD:8547773 |
NCBI chr X:140,164,341...140,176,057
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:6432916 |
RGD:8693324 |
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
protein:increased expression:skin: |
RGD |
PMID:21327568 |
RGD:8693728 |
NCBI chr 1:237,429,873...237,465,567
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
|
ISO |
DNA:polymorphisms:cds:HLA-DQA1*0104, HLA-DQA1*03011 (human) |
RGD |
PMID:18780165 |
RGD:5147619 |
NCBI chr20:4,577,057...4,581,650
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
|
ISO |
DNA:polymorphisms:cds:HLA-DQB1*0302, HLA-DQB1*0502 (human) |
RGD |
PMID:18780165 |
RGD:5147619 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
DNA:polymorphisms (human) DNA:polymorphism:cds:HLA-DRB1*0403, *0406, *1401, *1405, *1406 (human) |
RGD |
PMID:9347787 PMID:18780165 |
RGD:40818304, RGD:5147619 |
NCBI chr20:4,550,594...4,560,182
|
|
|
G |
Dsg3 |
desmoglein 3 |
|
ISS |
OMIM:169610 |
MouseDO |
|
|
NCBI chr18:12,074,321...12,105,954
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
|
ISO |
|
RGD |
PMID:28197992 |
RGD:14747041 |
NCBI chr20:4,598,475...4,604,118
|
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
susceptibility |
ISO |
mRNA:decreased expression:epidermis: DNA:polymorphism:cds:p.R16G(human) |
RGD |
PMID:8763426 PMID:15265530 |
RGD:8548488, RGD:8548492 |
NCBI chr18:57,912,760...57,914,802
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
no_association |
ISO |
DNA:SNP: :2184A>G (human) DNA:polymorphisms: :p.G82S, 1704G>T, 2245A>G (human) |
RGD |
PMID:12029499 PMID:12029499 |
RGD:8695975, RGD:8695975 |
NCBI chr20:4,152,758...4,155,956
|
|
G |
Alb |
albumin |
|
ISO |
|
RGD |
PMID:22607558 |
RGD:6483512 |
NCBI chr14:17,891,564...17,907,043
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
|
ISO |
protein:increased expression:keratinocyte |
RGD |
PMID:8304420 |
RGD:5509788 |
NCBI chr10:55,456,923...55,469,239
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:8919037 |
RGD:7421562 |
NCBI chr 1:227,287,713...227,306,739
|
|
G |
Ap1s3 |
adaptor related protein complex 1 subunit sigma 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr 9:88,399,109...88,458,396
|
|
G |
Apoe |
apolipoprotein E |
susceptibility |
ISO |
DNA:SNP: :3937C>T(human) DNA:polymorphism:exon: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16433808 PMID:16433808 PMID:19499236 |
RGD:7495788, RGD:7771595 |
NCBI chr 1:88,481,889...88,485,816
|
|
G |
Areg |
amphiregulin |
|
ISO |
|
RGD |
PMID:15955087 |
RGD:1578719 |
NCBI chr14:17,256,384...17,265,641
|
|
G |
Arpc4 |
actin related protein 2/3 complex, subunit 4 |
|
ISS |
OMIM:177900 | OMIM:601454 | OMIM:603935 | OMIM:604316 | OMIM:605364 | OMIM:605606 | OMIM:607857 | OMIM:610707 | OMIM:612410 | OMIM:612599 | OMIM:612950 | OMIM:614070 | OMIM:616106 |
MouseDO |
|
|
NCBI chr 4:148,077,799...148,088,427
|
|
G |
Bank1 |
B-cell scaffold protein with ankyrin repeats 1 |
susceptibility |
ISO |
DNA:haplotype: : rs10516487, rs3733197, rs17266594(human) |
RGD |
PMID:21989138 |
RGD:9684977 |
NCBI chr 2:227,203,998...227,474,008
|
|
G |
C2 |
complement C2 |
|
ISO |
DNA:polymorphism: :C2*2 (human) |
RGD |
PMID:6559061 |
RGD:7411727 |
NCBI chr20:3,944,722...3,975,006
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
|
ISO |
|
RGD |
PMID:21864505 |
RGD:15092073 |
NCBI chr11:17,994,856...18,971,895
|
|
G |
Card14 |
caspase recruitment domain family, member 14 |
|
ISO |
ClinVar Annotator: match by term: Psoriasis 2, pustular CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:22521418 PMID:22521419 PMID:23143594 PMID:24212883 |
|
NCBI chr10:105,064,941...105,100,132
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143594 |
|
NCBI chr 8:28,373,370...28,418,056
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:15654835 |
RGD:5509819 |
NCBI chr 2:5,707,633...5,817,213
|
|
G |
Cat |
catalase |
treatment |
ISO |
protein:increased activity:serum: CTD Direct Evidence: marker/mechanism protein:decreased activity:liver: protein:decreased activity:skin: |
CTD RGD |
PMID:12559600 PMID:12602965 PMID:24018880 PMID:12165738 |
RGD:9479159, RGD:9479744, RGD:9479170 |
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
protein:decreased expression:skin |
RGD |
PMID:12366416 |
RGD:8661784 |
NCBI chr 4:46,606,538...46,639,616
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
treatment |
ISO |
mRNA:increased expression:skin |
RGD |
PMID:10843722 PMID:16081850 PMID:22895364 |
RGD:7483581, RGD:7483625, RGD:7483594 |
NCBI chr 9:91,837,139...91,839,736
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
protein:increased expression:skin,monocyte: |
RGD |
PMID:15370700 |
RGD:8661734 |
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:decreased expression:T cell |
RGD |
PMID:23954573 |
RGD:8551838 |
NCBI chr 8:132,629,097...132,660,980
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
|
ISO |
mRNA:increased expression:skin |
RGD |
PMID:10843722 PMID:19662682 |
RGD:7483581, RGD:7483598 |
NCBI chr 1:55,022,037...55,055,857
|
|
G |
Cd40 |
CD40 molecule |
susceptibility |
ISO |
DNA:SNP:intron: (rs4810485) (human) |
RGD |
PMID:21645569 |
RGD:5490300 |
NCBI chr 3:174,209,113...174,224,592
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
mRNA,protein:increased expression:skin: |
RGD |
PMID:7636313 |
RGD:8662825 |
NCBI chr20:7,150,820...7,161,373
|
|
G |
Cfb |
complement factor B |
no_association |
ISO |
DNA:polymorphisms |
RGD |
PMID:6559061 PMID:2609873 |
RGD:7411727, RGD:7421520 |
NCBI chr20:3,975,271...3,981,138
|
|
G |
Cfh |
complement factor H |
severity |
ISO |
protein:increased expression:plasma |
RGD |
PMID:2973157 |
RGD:8662318 |
NCBI chr13:54,063,079...54,164,523
|
|
G |
Cfi |
complement factor I |
severity |
ISO |
protein:increased expression:plasma |
RGD |
PMID:2973157 |
RGD:8662318 |
NCBI chr 2:221,062,206...221,104,790
|
|
G |
Clu |
clusterin |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:23522962 |
RGD:9068388 |
NCBI chr15:44,336,619...44,375,861
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
|
RGD |
PMID:24001377 |
RGD:8662328 |
NCBI chr11:96,072,371...96,091,956
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12559600 |
|
NCBI chr 2:104,368,336...104,427,119
|
|
G |
Crp |
C-reactive protein |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:serum: |
CTD RGD |
PMID:12559600 PMID:22503884 PMID:22754198 |
RGD:6482313, RGD:9495927 |
NCBI chr13:87,694,062...87,695,978
|
|
G |
Csf2 |
colony stimulating factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7744320 |
|
NCBI chr10:38,887,692...38,889,673
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953187 |
|
NCBI chr16:78,920,549...80,520,710
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
treatment |
ISO |
|
RGD |
PMID:10974034 |
RGD:7411683 |
NCBI chr 9:69,812,859...69,819,959
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
DNA:SNP, missense mutation:intron, cds: , p.T280M (human) |
RGD |
PMID:17002687 |
RGD:9491384 |
NCBI chr 8:128,661,294...128,679,048
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
susceptibility |
ISO |
DNA:missense mutation, SNP:exon, 3' utr:2455A>G, 3801T>C (human) |
RGD |
PMID:12713578 |
RGD:5147677 |
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12711469 |
|
NCBI chr 1:90,437,741...90,453,073
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
|
ISO |
mRNA:decreased expression:skin |
RGD |
PMID:22924482 |
RGD:7495852 |
NCBI chr10:17,184,853...17,187,646
|
|
G |
Eln |
elastin |
treatment |
ISO |
|
RGD |
PMID:6893335 |
RGD:9585764 |
NCBI chr12:27,604,983...27,648,413
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
|
ISO |
|
RGD |
PMID:17495954 |
RGD:10395383 |
NCBI chr 6:13,543,252...13,626,147
|
|
G |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953187 PMID:20953190 PMID:23291587 PMID:24212883 |
|
NCBI chr 2:5,666,337...5,705,256
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
|
ISO |
mRNA:increased expression:skin (human) |
RGD |
PMID:16283139 |
RGD:1578463 |
NCBI chr 2:93,672,451...93,676,186
|
|
G |
Fbxl19 |
F-box and leucine-rich repeat protein 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953189 |
|
NCBI chr 1:191,786,981...191,811,314
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
|
ISO |
mRNA:increased expression:dermal dendritic cell |
RGD |
PMID:20471070 |
RGD:5147919 |
NCBI chr13:85,813,516...85,830,269
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
disease_progression |
ISO |
protein:increased expression:serum: |
RGD |
PMID:20980160 |
RGD:8552359 |
NCBI chr12:12,333,050...12,504,750
|
|
G |
Gba1 |
glucosylceramidase beta 1 |
|
ISO |
|
RGD |
PMID:15610510 |
RGD:5508434 |
NCBI chr 2:176,902,141...176,916,015
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953187 PMID:24212883 |
|
NCBI chr15:35,375,977...35,393,817
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
protein:increased expression:epidermis: |
RGD |
PMID:21805023 |
RGD:5491007 |
NCBI chr 1:210,767,237...210,770,242
|
|
G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18722346 |
|
NCBI chr12:38,387,163...38,389,149
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:23517877 PMID:17495954 |
RGD:8695945, RGD:10395383 |
NCBI chr 6:98,357,788...98,405,068
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment severity |
ISO |
protein:increased expression:serum |
RGD |
PMID:2015706 PMID:8094011 PMID:16181457 |
RGD:8158118, RGD:8547688, RGD:8547579 |
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953190 |
|
NCBI chr 3:67,635,924...67,683,968
|
|
G |
Ifnlr1 |
interferon, lambda receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953190 |
|
NCBI chr 5:153,203,597...153,225,911
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
mRNA,protein:increased expression:skin: |
RGD |
PMID:21241374 |
RGD:8549492 |
NCBI chr 7:24,169,608...24,249,446
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
|
ISO |
|
RGD |
PMID:16397523 |
RGD:7495754 |
NCBI chr16:76,021,968...76,075,717
|
|
G |
Il10 |
interleukin 10 |
onset |
ISO |
DNA:SNP:promoter:-1082G>A (human) |
RGD |
PMID:11298547 |
RGD:7829824 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il12b |
interleukin 12B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19169254 PMID:19169255 PMID:20953190 |
|
NCBI chr10:29,390,300...29,405,194
|
|
G |
Il13 |
interleukin 13 |
no_association susceptibility |
ISO |
DNA:SNP, missense mutation:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds: (rs20541) (human) |
CTD RGD |
PMID:19169254 PMID:20953190 PMID:21349879 PMID:23617596 |
RGD:8549517, RGD:8549593 |
NCBI chr10:38,290,926...38,293,483
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
|
ISO |
mRNA:increased expression:skin |
RGD |
PMID:14527737 |
RGD:8549525 |
NCBI chr X:120,213,670...120,294,777
|
|
G |
Il17a |
interleukin 17A |
treatment |
ISO |
mRNA:protein:increased expression:epidermis (human) |
RGD |
PMID:24286371 PMID:20926833 PMID:21172868 PMID:23359500 PMID:23359500 |
RGD:8698656, RGD:9068415, RGD:9068413, RGD:8698663, RGD:8698663 |
NCBI chr 9:30,640,844...30,644,331
|
|
G |
Il17ra |
interleukin 17 receptor A |
|
ISO |
ClinVar Annotator: match by term: Psoriasis |
ClinVar |
|
|
NCBI chr 4:155,339,742...155,362,382
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
protein:increased expression:plasma |
RGD |
PMID:22291810 PMID:17611614 |
RGD:8655900, RGD:8655919 |
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7744320 |
|
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il2 |
interleukin 2 |
disease_progression |
ISO |
|
RGD |
PMID:2448994 |
RGD:10047079 |
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il20 |
interleukin 20 |
|
ISO |
associated with Respiratory Tract Infections;DNA:SNP:enhancer:-1723C>G (rs1713239) (human) |
RGD |
PMID:21109726 |
RGD:5147391 |
NCBI chr13:44,933,249...44,936,893
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19169254 PMID:20953190 PMID:21348542 |
|
NCBI chr 7:1,306,320...1,308,434
|
|
G |
Il23r |
interleukin 23 receptor |
susceptibility |
ISO |
DNA:SNP:cds:p.R381Q(human) ClinVar Annotator: match by term: Psoriasis, protection against CTD Direct Evidence: marker/mechanism DNA:SNP: :rs11805303(human) DNA:SNPs: :rs1884444,rs10889677(human); |
ClinVar CTD RGD |
PMID:12023369 PMID:17068223 PMID:17447842 PMID:17587057 PMID:17786191 PMID:17804789 PMID:18438406 PMID:19122664 PMID:19169254 PMID:20228799 PMID:20953190 PMID:24212883 PMID:25741868 PMID:28492532 PMID:17587057 PMID:20978829 PMID:23093364 More...
|
RGD:8549569, RGD:8549602, RGD:8549574 |
NCBI chr 4:97,910,230...98,003,759
|
|
G |
Il25 |
interleukin 25 |
|
ISO |
protein:increased expression:arm skin |
RGD |
PMID:23657503 |
RGD:39128244 |
NCBI chr15:32,378,750...32,382,141
|
|
G |
Il3 |
interleukin 3 |
|
ISO |
protein: decreased expression |
RGD |
PMID:19889595 |
RGD:5686909 |
NCBI chr10:38,906,460...38,908,810
|
|
G |
Il36rn |
interleukin 36 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr 3:27,442,679...27,449,306
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19169254 PMID:15039646 PMID:19729876 |
RGD:7829812, RGD:7829826 |
NCBI chr10:38,272,003...38,277,549
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16844318 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
ISO |
|
RGD |
PMID:23018031 |
RGD:7495784 |
NCBI chr X:156,919,927...156,929,825
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO ISS |
OMIM:177900 | OMIM:601454 | OMIM:602723 | OMIM:603935 | OMIM:604316 | OMIM:605364 | OMIM:605606 | OMIM:607857 | OMIM:610707 | OMIM:612410 | OMIM:612599 | OMIM:612950 | OMIM:614070 | OMIM:616106 |
MouseDO RGD |
PMID:19812597 |
RGD:6482221 |
NCBI chr20:11,061,009...11,097,242
|
|
G |
Kdr |
kinase insert domain receptor |
treatment |
ISO |
mRNA:increased expression:skin: |
RGD |
PMID:23732650 PMID:20071151 |
RGD:8552361, RGD:8552376 |
NCBI chr14:32,572,031...32,615,204
|
|
G |
Lce3e |
late cornified envelope 3E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19169253 |
|
NCBI chr 2:181,274,092...181,275,265
|
|
G |
Lpin2 |
lipin 2 |
|
ISO |
ClinVar Annotator: match by term: Psoriasis |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 9:118,529,988...118,604,796
|
|
G |
Lta |
lymphotoxin alpha |
susceptibility |
ISO |
DNA:SNP:intron:IVS1 (human) |
RGD |
PMID:12709814 |
RGD:8548775 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:polymorphism:cds: |
RGD |
PMID:23113841 |
RGD:8693722 |
NCBI chr 1:237,429,873...237,465,567
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10384915 PMID:22499302 |
RGD:6483515 |
NCBI chr 1:199,926,150...199,952,847
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:22151390 |
RGD:329845865 |
NCBI chr 6:55,152,756...55,189,547
|
|
G |
Nat2 |
N-acetyltransferase 2 |
susceptibility |
ISO |
DNA:polymorphisms: : |
RGD |
PMID:19334527 |
RGD:8552687 |
NCBI chr16:26,974,874...27,005,191
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953190 |
|
NCBI chr 6:78,593,844...78,597,307
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953189 |
|
NCBI chr10:64,313,335...64,349,221
|
|
G |
Pcna |
proliferating cell nuclear antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10384915 |
|
NCBI chr 3:139,951,948...139,955,820
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10815854 |
|
NCBI chr 4:150,095,743...150,221,104
|
|
G |
Psmb9 |
proteasome 20S subunit beta 9 |
|
ISO |
|
RGD |
PMID:17581627 |
RGD:6482263 |
NCBI chr20:4,668,952...4,674,421
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 |
no_association susceptibility onset |
ISO |
DNA:missense mutation:cds:p.R620W (rs2476601) (human) DNA:missense mutation:cds:1858C>T (p.R620W) (rs2476601) (human) DNA:SNP:3' utr: (rs3789604) (human) DNA:SNPs:intron, 3' utr: (rs1217414, rs3789604) (human) |
RGD |
PMID:18341666 PMID:20039785 PMID:18923449 PMID:18341666 |
RGD:7829762, RGD:7829765, RGD:7829764, RGD:7829762 |
NCBI chr 2:194,055,165...194,103,209
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953187 |
|
NCBI chr10:28,394,940...28,406,410
|
|
G |
Rbp4 |
retinol binding protein 4 |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:22151390 |
RGD:329845865 |
NCBI chr 1:245,306,349...245,313,551
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953190 |
|
NCBI chr14:101,891,238...101,922,324
|
|
G |
Ren |
renin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:3540694 |
|
NCBI chr13:47,348,312...47,359,539
|
|
G |
Rig1 |
RNA sensor RIG-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143594 |
|
NCBI chr 5:60,117,398...60,165,995
|
|
G |
Rnf114 |
ring finger protein 114 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953190 |
|
NCBI chr 3:176,641,456...176,653,262
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
DNA:polymorphisms:cds:HLA-DQA1*0104, HLA-DQA1*0201, HLA-DQA1*0501 (human) |
RGD |
PMID:15009387 |
RGD:5147797 |
NCBI chr20:4,577,057...4,581,650
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
DNA:polymorphisms:cds:HLA-DQB1*0201, HLA-DQB1*0303 (human) |
RGD |
PMID:15009387 |
RGD:5147797 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143594 |
|
NCBI chr 5:152,644,270...152,702,835
|
|
G |
S100a7a |
S100 calcium binding protein A7A |
|
ISS |
|
MouseDO |
|
|
NCBI chr 2:178,448,983...178,453,424
|
|
G |
Serpinb8 |
serpin family B member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953187 |
|
NCBI chr13:24,141,557...24,164,894
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
mRNA:increased expression:skin: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:7744320 PMID:7744320 |
RGD:8547526 |
NCBI chr 1:50,043,323...50,050,168
|
|
G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
ISS |
OMIM:177900 | OMIM:601454 | OMIM:602723 | OMIM:603935 | OMIM:604316 | OMIM:605364 | OMIM:605606 | OMIM:607857 | OMIM:610707 | OMIM:612410 | OMIM:612599 | OMIM:612950 | OMIM:614070 | OMIM:616106 |
MouseDO |
|
|
NCBI chr 6:112,679,623...112,762,470
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
treatment |
ISO ISS |
CTD Direct Evidence: marker/mechanism |
MouseDO CTD RGD |
PMID:23143594 PMID:23594598 PMID:20811392 |
RGD:8694295, RGD:8694306 |
NCBI chr10:86,311,528...86,363,513
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
susceptibility |
ISO |
DNA:SNP:intron:IVS3 (rs7574865) (human) |
RGD |
PMID:19500629 |
RGD:8661715 |
NCBI chr 9:56,964,617...57,080,523
|
|
G |
Tagap |
T-cell activation RhoGTPase activating protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143594 |
|
NCBI chr 1:49,575,750...49,584,747
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:missense mutation, haplotype:cds:p.I333V (1207A>G) (human) |
RGD |
PMID:11194890 |
RGD:8548788 |
NCBI chr20:4,658,171...4,668,543
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:SNPs:CDs:p.T665A, Q687Q(human) |
RGD |
PMID:17581627 |
RGD:6482263 |
NCBI chr20:4,638,257...4,652,296
|
|
G |
Tgfa |
transforming growth factor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7519033 |
|
NCBI chr 4:120,175,549...120,258,342
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
severity |
ISO |
protein:increased expression:serum |
RGD |
PMID:15072741 |
RGD:7394851 |
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
mRNA:increased expression:mononuclear cell: |
RGD |
PMID:23457721 |
RGD:7777173 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
mRNA:increased expression:mononuclear cell: |
RGD |
PMID:23457721 |
RGD:7777173 |
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility |
ISO |
DNA:SNP: :-238G>A(rs361525)(human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:7744320 PMID:16844318 PMID:9326391 PMID:16821276 |
RGD:7394813, RGD:7401180 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19169254 PMID:20953190 |
|
NCBI chr 1:15,528,921...15,543,993
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
treatment |
ISO |
|
RGD |
PMID:15998370 |
RGD:8661740 |
NCBI chr 4:159,837,119...159,849,817
|
|
G |
Tnip1 |
TNFAIP3 interacting protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19169254 PMID:20953190 |
|
NCBI chr10:39,537,759...39,585,038
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10384915 |
|
NCBI chr10:54,798,871...54,810,300
|
|
G |
Traf3ip2 |
Traf3 interacting protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953186 PMID:20953188 PMID:20953190 |
|
NCBI chr20:44,565,992...44,609,240
|
|
G |
Ttc7a |
tetratricopeptide repeat domain 7A |
|
ISS |
OMIM:177900 | OMIM:601454 | OMIM:602723 | OMIM:603935 | OMIM:604316 | OMIM:605364 | OMIM:605606 | OMIM:607857 | OMIM:610707 | OMIM:612410 | OMIM:612599 | OMIM:612950 | OMIM:614070 | OMIM:616106 |
MouseDO |
|
|
NCBI chr 6:12,912,822...13,015,374
|
|
G |
Tyk2 |
tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953190 |
|
NCBI chr 8:27,918,054...27,943,319
|
|
G |
Vdr |
vitamin D receptor |
treatment no_association susceptibility |
ISO |
DNA:silent mutation:cds:pI352 (rs731236) (human) DNA:SNPs, haplotype:promoter, exon:-1012A>G, (rs731236, rs2228570) (human) DNA:SNPs:intron, cds: (rs731236, rs1544410, rs7975232) (human) DNA:SNPs, haplotype:intron, cds, enhancer:multiple DNA:SNPs:exon:multiple DNA:SNP:promoter:-1012A>G (rs4516035) (human) DNA:silent mutation:cds: (rs731236) (human) |
GAD RGD |
PMID:15118671 PMID:20716226 PMID:15864137 PMID:21951018 PMID:24055231 PMID:24320988 PMID:24320988 PMID:17763859 More...
|
RGD:1331525, RGD:8158081, RGD:8158072, RGD:8158062, RGD:8158056, RGD:8157635, RGD:8157635, RGD:8157633 |
NCBI chr 7:130,864,764...130,916,757
|
|
G |
Vegfa |
vascular endothelial growth factor A |
onset disease_progression treatment |
ISO ISS |
mRNA:increased expression:skin: CTD Direct Evidence: marker/mechanism DNA:polymorphism: :405C>G(human) protein:increased expression:serum: |
MouseDO CTD RGD |
PMID:16385345 PMID:8064230 PMID:14962110 PMID:20980160 PMID:19995970 |
RGD:7421592, RGD:8552645, RGD:8552359, RGD:8549646 |
NCBI chr 9:22,452,854...22,468,194
|
|
G |
Vnn1 |
vanin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19322213 |
|
NCBI chr 1:23,356,324...23,366,629
|
|
G |
Vnn3 |
vanin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19322213 |
|
NCBI chr 1:23,390,596...23,402,858
|
|
G |
Zc3h12c |
zinc finger CCCH type containing 12C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23143594 |
|
NCBI chr 8:61,340,446...61,404,932
|
|
G |
Zfp141 |
zinc finger protein 141 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953187 PMID:24212883 |
|
NCBI chr 1:102,267,194...102,300,911
|
|
|
G |
Traf3ip2 |
Traf3 interacting protein 2 |
|
ISO |
ClinVar Annotator: match by term: Psoriasis 13, susceptibility to |
ClinVar OMIM |
PMID:20953186 PMID:20953188 PMID:22581863 PMID:24033266 PMID:24120361 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr20:44,565,992...44,609,240
|
|
|
G |
Ap1s3 |
adaptor related protein complex 1 subunit sigma 3 |
susceptibility |
ISO |
ClinVar Annotator: match by term: AP1S3-related condition | ClinVar Annotator: match by term: Psoriasis 15, pustular, susceptibility to |
OMIM ClinVar |
PMID:24033266 PMID:24791904 PMID:25741868 PMID:28887889 |
|
NCBI chr 9:88,399,109...88,458,396
|
|
|
G |
Card14 |
caspase recruitment domain family, member 14 |
|
ISO ISS |
ClinVar Annotator: match by term: PSORIASIS 2 | ClinVar Annotator: match by term: Psoriasis 2 OMIM:602723 |
OMIM ClinVar MouseDO |
PMID:8178173 PMID:9536098 PMID:15689454 PMID:17576681 PMID:18256691 PMID:22521418 PMID:22521419 PMID:23648549 PMID:24033266 PMID:25741868 PMID:26203641 PMID:26255310 PMID:26358359 PMID:28492532 PMID:29477734 PMID:30018619 PMID:30387497 PMID:30697821 PMID:31971603 PMID:36174714 PMID:36221432 More...
|
|
NCBI chr10:105,064,941...105,100,132
|
|
G |
Sgsh |
N-sulfoglucosamine sulfohydrolase |
|
ISO |
ClinVar Annotator: match by term: PSORIASIS 2 | ClinVar Annotator: match by term: Psoriasis 2 |
ClinVar |
PMID:22521419 PMID:24033266 PMID:25741868 PMID:26203641 PMID:26255310 PMID:28492532 PMID:30018619 PMID:30697821 PMID:31971603 PMID:36174714 PMID:36221432 More...
|
|
NCBI chr10:105,095,336...105,112,037
|
|
|
G |
Il23r |
interleukin 23 receptor |
|
ISO |
ClinVar Annotator: match by term: IL23R-related condition |
OMIM ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 4:97,910,230...98,003,759
|
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20008919 |
|
NCBI chr15:22,098,191...22,113,145
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16936328 |
RGD:5683894 |
NCBI chr10:68,963,893...68,965,728
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
susceptibility |
ISO |
associated with Psoriasis;DNA:SNP:p.V64I(rs1799864)(human) |
RGD |
PMID:20153665 |
RGD:8661745 |
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19732956 |
|
NCBI chr10:54,880,562...54,882,441
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
susceptibility |
ISO |
DNA:polymorphisms: :4887C>A, 4889A>G (human) |
RGD |
PMID:15124938 |
RGD:5147746 |
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Fbxl19 |
F-box and leucine-rich repeat protein 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953189 |
|
NCBI chr 1:191,786,981...191,811,314
|
|
G |
Il12b |
interleukin 12B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953186 |
|
NCBI chr10:29,390,300...29,405,194
|
|
G |
Il13 |
interleukin 13 |
susceptibility |
ISO |
DNA:SNP, missense mutation:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human DNA:SNPs:promoter, exon:rs1800925, rs20541, rs848 (human) |
RGD |
PMID:21349879 PMID:19554022 |
RGD:8549517, RGD:8549552 |
NCBI chr10:38,290,926...38,293,483
|
|
G |
Il17a |
interleukin 17A |
severity treatment |
ISO |
|
RGD |
PMID:24567524 PMID:23361084 |
RGD:8698658, RGD:9068444 |
NCBI chr 9:30,640,844...30,644,331
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
susceptibility |
ISO |
DNA:SNP:enhancer: (rs3027898) (human) |
RGD |
PMID:20500689 |
RGD:7495783 |
NCBI chr X:156,919,927...156,929,825
|
|
G |
Lta |
lymphotoxin alpha |
treatment susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Psoriatic arthritis, susceptibility to |
OMIM CTD ClinVar RGD |
PMID:12426569 PMID:12746914 PMID:14681301 PMID:22480318 |
RGD:8548821 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17408446 |
|
NCBI chr10:12,288,514...12,303,337
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:9972954 |
RGD:7207129 |
NCBI chr 8:12,943,453...12,963,966
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
ISO |
|
RGD |
PMID:11796404 |
RGD:7241254 |
NCBI chr 8:12,925,267...12,938,828
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Psoriatic arthritis, susceptibility to |
ClinVar |
PMID:11385576 PMID:25741868 PMID:28492532 |
|
NCBI chr19:34,555,832...34,596,281
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953189 |
|
NCBI chr10:64,313,335...64,349,221
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19732956 |
|
NCBI chr 3:62,098,739...62,115,926
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:22751595 |
RGD:6771221 |
NCBI chr10:92,090,263...92,152,002
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 |
no_association |
ISO |
DNA: snp: cds: rs2476601 DNA:missense mutation: :R620W (rs2476601) (human) |
RGD |
PMID:21410964 PMID:15934099 |
RGD:6484592, RGD:6484550 |
NCBI chr 2:194,055,165...194,103,209
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20008919 |
|
NCBI chr 9:23,661,278...23,990,248
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
no_association |
ISO |
DNA:SNP: :rs744166 (human) DNA:SNP: :rs2293152 (human) |
RGD |
PMID:23127549 PMID:23127549 |
RGD:8694309, RGD:8694309 |
NCBI chr10:86,311,528...86,363,513
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
ISO |
DNA:SNP: :rs10181656 (human) |
RGD |
PMID:22328738 |
RGD:8661724 |
NCBI chr 9:56,964,617...57,080,523
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility |
ISO |
DNA:SNP: :-238G>A(rs361525)(human) ClinVar Annotator: match by term: Psoriatic arthritis, susceptibility to CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:8056188 PMID:9818939 PMID:10450718 PMID:11261930 PMID:11506397 PMID:11826025 PMID:11896460 PMID:12485196 PMID:12746914 PMID:12759288 PMID:14681301 PMID:14718719 PMID:16418737 PMID:16720636 PMID:16865291 PMID:16909270 PMID:18050183 PMID:18713756 PMID:19365401 PMID:19732956 PMID:22760475 PMID:22992668 PMID:9326391 More...
|
RGD:7394813 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Traf3ip2 |
Traf3 interacting protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20953186 PMID:20953188 |
|
NCBI chr20:44,565,992...44,609,240
|
|
|
G |
Il1f10 |
interleukin 1 family member 10 |
|
ISO |
ClinVar Annotator: match by term: Generalized pustular psoriasis |
ClinVar |
PMID:19494218 PMID:21792839 PMID:21848462 PMID:22940634 PMID:23698098 PMID:26100510 PMID:28492532 More...
|
|
NCBI chr 3:27,470,798...27,473,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
ClinVar Annotator: match by term: Generalized pustular psoriasis |
ClinVar |
PMID:19494218 PMID:21792839 PMID:22940634 PMID:23698098 PMID:26100510 PMID:28492532 More...
|
|
NCBI chr 3:27,509,836...27,525,738
|
|
G |
Il36rn |
interleukin 36 receptor antagonist |
|
ISO |
ClinVar Annotator: match by term: ACRODERMATITIS CONTINUA OF HALLOPEAU | ClinVar Annotator: match by term: Generalized pustular psoriasis | ClinVar Annotator: match by term: IL36RN-related condition | ClinVar Annotator: match by term: Psoriasis 14, pustular |
OMIM ClinVar |
PMID:6147717 PMID:9536098 PMID:16199547 PMID:17576681 PMID:19494218 PMID:21792839 PMID:21839423 PMID:21848462 PMID:22428995 PMID:22903787 PMID:22940634 PMID:23303454 PMID:23358093 PMID:23428889 PMID:23648549 PMID:23698098 PMID:23792462 PMID:23834760 PMID:23863864 PMID:24019411 PMID:24656634 PMID:24898045 PMID:24979538 PMID:25212972 PMID:25427108 PMID:25458002 PMID:25468355 PMID:25615897 PMID:25741868 PMID:25989471 PMID:26100510 PMID:26147717 PMID:26589685 PMID:26676204 PMID:27096382 PMID:27220475 PMID:27388993 PMID:27542682 PMID:27900482 PMID:28063630 PMID:28492532 PMID:28887889 PMID:29030861 PMID:29665114 PMID:29892664 PMID:30036598 PMID:30609409 PMID:30953287 PMID:32301172 PMID:33729564 PMID:34339530 PMID:34903506 PMID:37414245 More...
|
|
NCBI chr 3:27,442,679...27,449,306
|
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
DNA:SNP:intron:IVS1 (human) |
RGD |
PMID:12691703 |
RGD:8548804 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Tnf |
tumor necrosis factor |
no_association |
ISO |
DNA:SNPs:promoter:multiple DNA:SNPs, haplotype:5' utr:multiple |
RGD |
PMID:11019918 PMID:12691703 |
RGD:8548803, RGD:8548804 |
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Bach2 |
BTB domain and CNC homolog 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr 5:51,428,802...51,779,030
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:12121667 |
RGD:7401277 |
NCBI chr 9:2,174,412...2,201,339
|
|
G |
C4a |
complement C4A |
|
ISO |
associated with Graves Disease |
RGD |
PMID:21943165 |
RGD:5688264 |
NCBI chr20:4,010,306...4,024,707
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr 1:265,442,647...265,481,938
|
|
G |
Cat |
catalase |
susceptibility no_association |
ISO |
DNA:SNP,haplotype:promoter,cds:-89A>T,389C>T(human) protein:decreased activity:skin: DNA:SNPs:promoter,exon: -89A>T rs7943316), 389C>T (rs769217)(human) |
RGD |
PMID:20613769 PMID:19439879 PMID:23868633 |
RGD:9479149, RGD:9479169, RGD:9479150 |
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526340 |
|
NCBI chr 1:55,022,037...55,055,857
|
|
G |
Cd44 |
CD44 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr 3:109,610,824...109,699,776
|
|
G |
Cd80 |
Cd80 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr11:75,760,073...75,798,978
|
|
G |
Clnk |
cytokine-dependent hematopoietic cell linker |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr14:76,136,446...76,315,364
|
|
G |
Clu |
clusterin |
|
ISO |
|
RGD |
PMID:7558712 |
RGD:8699503 |
NCBI chr15:44,336,619...44,375,861
|
|
G |
Comt |
catechol-O-methyltransferase |
no_association |
ISO |
DNA:polymorphism: :p.V158M (human) |
RGD |
PMID:19112571 PMID:24915010 |
RGD:8662333, RGD:8662336 |
NCBI chr11:96,072,371...96,091,956
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
susceptibility no_association |
ISO |
associated with Autoimmune Diseases;DNA:polymorphisms: : DNA:SNP:exon:+49A>G rs231775)(human) DNA:SNPs:multiple: DNA:SNP:3'UTR:rs3087243(human) |
RGD |
PMID:15649153 PMID:19129082 PMID:18200060 PMID:21794098 |
RGD:7411687, RGD:7411699, RGD:7411697, RGD:7411696 |
NCBI chr 9:69,812,859...69,819,959
|
|
G |
Esr1 |
estrogen receptor 1 |
susceptibility no_association |
ISO |
DNA:SNP:intron DNA:SNP:exon |
RGD |
PMID:15381239 PMID:15381239 |
RGD:8552976, RGD:8552976 |
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Foxd3 |
forkhead box D3 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Autoimmune disease, susceptibility to, 1 |
ClinVar OMIM |
PMID:16098053 |
|
NCBI chr 5:119,450,532...119,452,898
|
|
G |
Foxp1 |
forkhead box P1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526340 |
|
NCBI chr 4:133,117,346...133,808,647
|
|
G |
Hgf |
hepatocyte growth factor |
treatment |
ISO |
|
RGD |
PMID:16117796 |
RGD:8548598 |
NCBI chr 4:19,628,902...19,700,467
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
treatment |
ISO |
|
RGD |
PMID:23447019 |
RGD:8662840 |
NCBI chr20:3,875,411...3,877,866
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr 3:67,635,924...67,683,968
|
|
G |
Ifng |
interferon gamma |
susceptibility onset |
ISO |
DNA:repeats:intron:rs3138557(human) DNA:polymorphism:intron:rs2430561(human) |
RGD |
PMID:23777204 PMID:23777204 |
RGD:8157616, RGD:8157616 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Ikzf4 |
IKAROS family zinc finger 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr 7:1,643,379...1,687,524
|
|
G |
Il13 |
interleukin 13 |
treatment |
ISO |
|
RGD |
PMID:23680073 |
RGD:8549591 |
NCBI chr10:38,290,926...38,293,483
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:22342018 |
RGD:8663475 |
NCBI chr 9:30,640,844...30,644,331
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
protein:increased expression:skin CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:28836394 PMID:16911396 |
RGD:7794736 |
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:22342018 |
RGD:8663475 |
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:22342018 |
RGD:8663475 |
NCBI chr10:38,272,003...38,277,549
|
|
G |
Itk |
IL2-inducible T-cell kinase |
|
ISO |
ClinVar Annotator: match by term: Vitiligo-associated multiple autoimmune disease susceptibility 1 |
ClinVar |
PMID:28492532 PMID:32628964 PMID:32888943 |
|
NCBI chr10:31,254,667...31,316,004
|
|
G |
Kif1b |
kinesin family member 1B |
|
ISO |
ClinVar Annotator: match by term: Vitiligo |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 5:164,890,778...165,025,848
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility no_association |
ISO |
DNA:polymorphism:exon: DNA:polymorphisms:promoter, exon: |
RGD |
PMID:17337399 PMID:19416237 |
RGD:8693723, RGD:8693724 |
NCBI chr 1:237,429,873...237,465,567
|
|
G |
Mc1r |
melanocortin 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr19:68,360,950...68,363,877
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28836394 |
|
NCBI chr 3:81,001,529...81,031,165
|
|
G |
Nlrp1a |
NLR family, pyrin domain containing 1A |
|
ISO |
ClinVar Annotator: match by term: Vitiligo-associated multiple autoimmune disease susceptibility 1 |
ClinVar OMIM |
PMID:17377159 PMID:25741868 PMID:27662089 PMID:28492532 |
|
NCBI chr10:56,277,134...56,332,229
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28836394 |
|
NCBI chr 2:34,612,946...34,697,660
|
|
G |
Psmb9 |
proteasome 20S subunit beta 9 |
|
ISO |
|
RGD |
PMID:14551602 |
RGD:1578358 |
NCBI chr20:4,668,952...4,674,421
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 |
|
ISO |
DNA: snp : cds: rs2476601 DNA:polymorphism: :1858C>T (p.R620W) (human) |
RGD |
PMID:16015369 PMID:18426414 |
RGD:6484552, RGD:7829737 |
NCBI chr 2:194,055,165...194,103,209
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
DNA:polymorphisms:: HLA-DQA1*0302, HLA-DQA1*0601, HLA-DQA1*0501; |
RGD |
PMID:16409268 |
RGD:8547566 |
NCBI chr20:4,577,057...4,581,650
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
DNA:polymorphisms (human) DNA:polymorphism:HLA-DQB1*0201(human) |
RGD |
PMID:16420246 PMID:9653015 |
RGD:5147644, RGD:36174006 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
DNA:polymorphisms (human) DNA:polymorphism: : HLA-DRB1*0701(human) |
RGD |
PMID:16420246 PMID:9653015 |
RGD:5147644, RGD:36174006 |
NCBI chr20:4,550,594...4,560,182
|
|
G |
Sh2b3 |
SH2B adaptor protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr12:40,391,755...40,414,336
|
|
G |
Sla |
src-like adaptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr 7:100,423,467...100,473,840
|
|
G |
Sod2 |
superoxide dismutase 2 |
disease_progression |
ISO |
DNA, mRNA, protein:SNPs, increased expression:cds:p.L84F (rs11575993), p.T58I (rs35289490), skin, leukocyte (human) |
RGD |
PMID:24036105 |
RGD:8547522 |
NCBI chr 1:50,043,323...50,050,168
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:22342018 |
RGD:8663475 |
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Tlr2 |
toll-like receptor 2 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.R753Q(human) |
RGD |
PMID:22429552 |
RGD:7777152 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr4 |
toll-like receptor 4 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.D299G(human) |
RGD |
PMID:22429552 |
RGD:7777152 |
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:skin CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:28836394 PMID:16911396 |
RGD:7794736 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tob2 |
transducer of ERBB2, 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561518 |
|
NCBI chr 7:115,242,843...115,251,563
|
|
G |
Tyr |
tyrosinase |
severity |
ISO |
|
RGD |
PMID:22834951 PMID:8697641 |
RGD:8694387, RGD:8694409 |
NCBI chr 1:150,527,687...150,622,857
|
|
G |
Vdr |
vitamin D receptor |
no_association |
ISO |
DNA:SNPs, haplotype: :multiple DNA:SNP:exon:rs2228570 (human) DNA:SNPs: :rs731236, rs1544410, rs7975232 (human) |
RGD |
PMID:22738935 PMID:22762534 PMID:22762534 |
RGD:8158061, RGD:8158066, RGD:8158066 |
NCBI chr 7:130,864,764...130,916,757
|
|
|
G |
Ifng |
interferon gamma |
|
ISO |
associated with uveitis;protein:increased expression:aqueous humor: |
RGD |
PMID:21334264 |
RGD:8142356 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO |
protein:decreased expression:T cell |
RGD |
PMID:21297967 |
RGD:6482200 |
NCBI chr20:11,061,009...11,097,242
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
DNA:polymorphism: : HLA-DQA1*0301 |
RGD |
PMID:11835809 |
RGD:8547565 |
NCBI chr20:4,577,057...4,581,650
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
DNA:polymorphisms:cds:multiple (human) DNA:snps:promoter:g.-227G>A, g.-189C>A (human) |
RGD |
PMID:17605936 PMID:19176112 |
RGD:7421525, RGD:7421581 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
DNA:polymorphism (human) DNA:polymorphism: :HLA-DRB1*0405(human) DNA:polymorphisms: :HLA-DRB1*0405, HLA-DRB1*0410(human) DNA:polymorphisms (human) |
RGD |
PMID:15603876 PMID:9548078 PMID:20216938 PMID:10527396 |
RGD:5147653, RGD:7365099, RGD:7365067, RGD:5147857 |
NCBI chr20:4,550,594...4,560,182
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
ISO |
DNA:SNP: :rs7574865 (human) |
RGD |
PMID:20438790 |
RGD:8661713 |
NCBI chr 9:56,964,617...57,080,523
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
associated with uveitis;protein:increased expression:aqueous humor: |
RGD |
PMID:21334264 |
RGD:8142356 |
NCBI chr20:3,626,685...3,629,303
|
|